Difference between revisions of "O2k-Publications: Topics"
From Bioblast
| Line 14: | Line 14: | ||
== Mitochondrial physiology: MiP areas == | == Mitochondrial physiology: MiP areas == | ||
* [[O2k-Publications: Mitochondrial medicine|mt-Medicine]] ({{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[MiP area::mt-Medicine]] |format=count}} entries) | * [[O2k-Publications: Mitochondrial medicine|mt-Medicine]] ({{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[MiP area::mt-Medicine]] |format=count}} entries) | ||
* [[O2k-Publications: Exercise physiology;nutrition;life style|Exercise physiology;nutrition;life style]] | * [[O2k-Publications: Exercise physiology;nutrition;life style|Exercise physiology;nutrition;life style]] | ||
* [[O2k-Publications: Comparative MiP;environmental MiP|Comparative MiP;environmental MiP]] | |||
* [[O2k-Publications: Pharmacology;toxicology|Pharmacology;toxicology]] | * [[O2k-Publications: Pharmacology;toxicology|Pharmacology;toxicology]] | ||
* [[O2k-Publications: mt-Biogenesis;mt-density|mt-Biogenesis;mt-density]] | * [[O2k-Publications: mt-Biogenesis;mt-density|mt-Biogenesis;mt-density]] | ||
* [[O2k-Publications: Genetic knockout; overexpression|Genetic knockout;overexpression]] | |||
* [[O2k-Publications: Instruments;methods|Instruments;methods]] | * [[O2k-Publications: Instruments;methods|Instruments;methods]] | ||
| Line 22: | Line 24: | ||
== Pathological states == | == Pathological states == | ||
:: ''Alphabetical order'' | :: ''Alphabetical order'' | ||
* [[O2k-Publications: Aging;_senescence|Aging;senescence]] | |||
* [[O2k-Publications: Alzheimer's disease|Alzheimer's]] | |||
* [[O2k-Publications: Autism|Autism]] | |||
* [[O2k-Publications: Cancer|Cancer]] | |||
* [[O2k-Publications: Cardiovascular diseases|Cardiovascular]] | |||
* [[O2k-Publications: COPD|COPD]] | |||
* [[O2k-Publications: Diabetes 2|Diabetes]] | |||
* [[O2k-Publications: Inherited|Inherited]] | |||
* [[O2k-Publications: Infectious|Infectious]] | |||
* [[O2k-Publications: Myopathy|Myopathy]] | |||
* [[O2k-Publications: Neurodegenerative|Neurodegenerative]] | |||
* [[O2k-Publications: Obesity|Obesity]] | |||
* [[O2k-Publications: Parkinson's disease|Parkinson's]] | |||
* [[O2k-Publications: Sepsis|Sepsis]] | |||
* [[O2k-Publications: Other|Other]] | * [[O2k-Publications: Other|Other]] | ||
| Line 41: | Line 43: | ||
== Stress conditions == | == Stress conditions == | ||
:: ''Alphabetical order'' | :: ''Alphabetical order'' | ||
* [[O2k-Publications: Cell death|Cell death]] | |||
* [[O2k-Publications: Cryopreservation|Cryopreservation]] | |||
* [[O2k-Publications: Hypoxia|Hypoxia]] | |||
* [[O2k-Publications: Ischemia-Reperfusion Injury and Preservation|Ischemia-reperfusion injury and preservation]] | |||
* [[O2k-Publications: Mitochondrial Disease; Degenerative Disease and Defect|Mitochondrial disease;degenerative disease and defect]] | |||
* [[O2k-Publications: RONS;_Oxidative_stress|Oxidative stress;RONS]] | |||
* [[O2k-Publications: Permeability transition|Permeability transition]] | |||
* [[O2k-Publications: Temperature: hypothermia; hyperthermia|Temperature: hypothermia; hyperthermia]] | |||
| Line 165: | Line 167: | ||
== Coupling control states == | == Coupling control states == | ||
* [[O2k-Publications: OXPHOS |OXPHOS]] | |||
* [[O2k-Publications: ROUTINE |ROUTINE]] | |||
* [[O2k-Publications: ETS |ETS]] | |||
* [[O2k-Publications: LEAK |LEAK]] | |||
| Line 175: | Line 177: | ||
! # | ! # | ||
! O2k-Publications | ! O2k-Publications | ||
! MitoPedia: [[Pathway control state]]s | ! MitoPedia: [[Pathway control state]]s | ||
! Comment | ! Comment | ||
! O2k | |||
! Total | |||
|- | |- | ||
| 1 | | 1 | ||
| [[O2k-Publications: F |F]] | | [[O2k-Publications: F |F]] | ||
| style="text-align:left"|[[F-pathway control state]] | |||
| style="text-align:left"|Fatty acid oxidation, level 5 | |||
| {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::F]] |format=count}} | | {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::F]] |format=count}} | ||
| {{#ask:[[Category:Publications]][[Pathways::F]] |format=count}} | | {{#ask:[[Category:Publications]][[Pathways::F]] |format=count}} | ||
|- | |- | ||
| 2 | | 2 | ||
| [[O2k-Publications: N |N]] | | [[O2k-Publications: N |N]] | ||
| style="text-align:left"|[[N-pathway control state]] | |||
| style="text-align:left"|NADH-linked, level 4 | |||
| {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::N]] |format=count}} | | {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::N]] |format=count}} | ||
| {{#ask:[[Category:Publications]][[Pathways::N]] |format=count}} | | {{#ask:[[Category:Publications]][[Pathways::N]] |format=count}} | ||
|- | |- | ||
| 3 | | 3 | ||
| [[O2k-Publications: S |S]] | | [[O2k-Publications: S |S]] | ||
| style="text-align:left"|[[S-pathway control state]] | |||
| style="text-align:left"|Succinate-linked, level 3 | |||
| {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::S]] |format=count}} | | {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::S]] |format=count}} | ||
| {{#ask:[[Category:Publications]][[Pathways::S]] |format=count}} | | {{#ask:[[Category:Publications]][[Pathways::S]] |format=count}} | ||
|- | |- | ||
| 4 | | 4 | ||
| [[O2k-Publications: Gp |Gp]] | | [[O2k-Publications: Gp |Gp]] | ||
| style="text-align:left"|[[Gp-pathway control state]] | |||
| style="text-align:left"|Glycerophosphate-linked, level 3 | |||
| {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::Gp]] |format=count}} | | {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::Gp]] |format=count}} | ||
| {{#ask:[[Category:Publications]][[Pathways::Gp]] |format=count}} | | {{#ask:[[Category:Publications]][[Pathways::Gp]] |format=count}} | ||
|- | |- | ||
| 5 | | 5 | ||
| [[O2k-Publications: DQ |DQ]] | | [[O2k-Publications: DQ |DQ]] | ||
| style="text-align:left"|[[DQ-pathway control state]] | |||
| style="text-align:left"|Duorquinol-linked, level 2 | |||
| {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::DQ]] |format=count}} | | {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::DQ]] |format=count}} | ||
| {{#ask:[[Category:Publications]][[Pathways::DQ]] |format=count}} | | {{#ask:[[Category:Publications]][[Pathways::DQ]] |format=count}} | ||
|- | |- | ||
| 6 | | 6 | ||
| [[O2k-Publications: CIV |CIV]] | | [[O2k-Publications: CIV |CIV]] | ||
| style="text-align:left"|[[Complex IV single step]] | |||
| style="text-align:left"|Ascorbate & TMPD, level 1 | |||
| {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::CIV]] |format=count}} | | {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::CIV]] |format=count}} | ||
| {{#ask:[[Category:Publications]][[Pathways::CIV]] |format=count}} | | {{#ask:[[Category:Publications]][[Pathways::CIV]] |format=count}} | ||
|- | |- | ||
| 7 | | 7 | ||
| [[O2k-Publications: NS |NS]] | | [[O2k-Publications: NS |NS]] | ||
| style="text-align:left"|[[NS-pathway control state]] | |||
| style="text-align:left"|Convergent CI- and CII-linked electron flow to the [[Q-junction]] | |||
| {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::NS]] |format=count}} | | {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::NS]] |format=count}} | ||
| {{#ask:[[Category:Publications]][[Pathways::NS]] |format=count}} | | {{#ask:[[Category:Publications]][[Pathways::NS]] |format=count}} | ||
|- | |- | ||
| 8 | | 8 | ||
| [[O2k-Publications: Other combinations |Other combinations]] | | [[O2k-Publications: Other combinations |Other combinations]] | ||
| style="text-align:left"|[[Other combinations-pathway control state]] | |||
| style="text-align:left"| | |||
| {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::Other combinations]] |format=count}} | | {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::Other combinations]] |format=count}} | ||
| {{#ask:[[Category:Publications]][[Pathways::Other combinations]] |format=count}} | | {{#ask:[[Category:Publications]][[Pathways::Other combinations]] |format=count}} | ||
|- | |- | ||
| 9 | | 9 | ||
| [[O2k-Publications: ROX |ROX]] | | [[O2k-Publications: ROX |ROX]] | ||
| style="text-align:left"|[[Residual oxygen consumption]] | |||
| style="text-align:left"|includes non-mitochondrial respiration | |||
| {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::ROX]] |format=count}} | | {{#ask:[[Category:Publications]][[Instrument and method::Oxygraph-2k]][[Pathways::ROX]] |format=count}} | ||
| {{#ask:[[Category:Publications]][[Pathways::ROX]] |format=count}} | | {{#ask:[[Category:Publications]][[Pathways::ROX]] |format=count}} | ||
|- | |- | ||
|} | |} | ||
Revision as of 09:13, 10 November 2016
O2k-Publications: Topics
- Mitochondria and cell research
Mitochondrial physiology: MiP areas
- mt-Medicine (363 entries)
- Exercise physiology;nutrition;life style
- Comparative MiP;environmental MiP
- Pharmacology;toxicology
- mt-Biogenesis;mt-density
- Genetic knockout;overexpression
- Instruments;methods
Pathological states
- Alphabetical order
- Aging;senescence
- Alzheimer's
- Autism
- Cancer
- Cardiovascular
- COPD
- Diabetes
- Inherited
- Infectious
- Myopathy
- Neurodegenerative
- Obesity
- Parkinson's
- Sepsis
- Other
Stress conditions
- Alphabetical order
- Cell death
- Cryopreservation
- Hypoxia
- Ischemia-reperfusion injury and preservation
- Mitochondrial disease;degenerative disease and defect
- Oxidative stress;RONS
- Permeability transition
- Temperature: hypothermia; hyperthermia
Organisms
- Mammals
- Human
- Pig
- Horse
- Bovines
- Cat
- Dog
- Rabbit
- Mouse
- Rat
- Guinea pig
- Other mammals: including only mammals that are not listed as mammalian species above'.
- Model organisms
- Chicken (» Birds)
- Zebrafish (» Fishes)
- Drosophila (» Hexapods)
- Caenorhabditis elegans (» Nematodes)
- Artemia (» Crustaceans)
- Saccharomyces cerevisiae (» Fungi)
- Comparative MiP
- Non-mammals
- Birds (» Chicken)
- Reptiles - turtles, lizards, snakes, crocodiles, alligators
- Amphibians - frogs, toads, salamanders
- Fishes - bony fishes, carilaginous fishes (sharks, rays, skates) and jawless fishes (hagfish, lampreys); » Zebrafish
- Hexapods - insects, springtails; » Drosophila
- Crustaceans - crabs, shrimp, barnacles, etc.; » Artemia
- Annelids - polychaetes, e.g. lugworm Arenicola marina, oligochaetes, leeches
- Molluscs - gastropods, cephalopods, bivalves
- Nematodes » Caenorhabditis elegans
- Other invertebrates - urocordates (e.g. ascidians, sea squirts); cephalochordates (amphioxus, lancelets); echinoderms; chelicerates (e.g. spiders, scorpions, horseshoe crabs); myriapods (millipedes, centipedes); gastrotrichs; rotifers; ctenophores; nemerteans; tardigrades; platyhelminthes; cnidaria; porifera; ...
- Fungi - yeast, molds, mushrooms, etc.; » Saccharomyces cerevisiae
- Plants
- Protists - amoebas, ciliates, trypanosomes, dinoflagellates, diatoms, green algae, etc.
- Eubacteria - true bacteria, cyanobacteria, spirochetes
- Archaea - archaebacteria
Tissues and cells
- Tissues - alphabetical order
•• Fat •• Genital •• Heart •• Kidney •• Liver •• Lung;Gill •• Nervous system •• Skeletal muscle
- Cell types - alphabetical order
•• Blood cells •• Endothelial;epithelial;mesothelial cell •• Fibroblast •• Islet cell;pancreas;thymus •• Lymphocyte •• Platelet •• Stem cells
- Cell lines - alphabetical order
•• CHO •• HEK •• HeLa •• Neuroblastoma •• HUVEC •• Macrophage-derived cell lines
Preparations
- Intact organism •• Intact organ •• Intact cells •• Permeabilized cells •• Permeabilized tissue •• Homogenate •• Isolated mitochondria •• SMP •• Chloroplasts •• Enzyme •• Oxidase and biochemical oxidation
Enzymes
- Alphabetical order
•• Adenine nucleotide translocase •• Complex I •• Complex II;succinate dehydrogenase •• Complex III •• Complex IV;cytochrome c oxidase •• Complex V;ATP synthase •• Inner mt-membrane transporter •• Marker enzyme •• Supercomplex •• TCA cycle and matrix dehydrogenases •• Uncoupling protein
Regulation
- Alphabetical order
•• ADP •• ATP production •• Aerobic glycolysis •• Amino acid •• Calcium •• Coupling efficiency;uncoupling •• Cyt c •• Fatty acid •• Flux control •• Inhibitor •• Ion;substrate transport •• mt-Membrane potential •• Oxygen kinetics •• Q-junction effect •• Redox state •• Substrate •• Temperature •• Threshold;excess capacity •• Uncoupler
Coupling control states
Pathway control states
# O2k-Publications MitoPedia: Pathway control states Comment O2k Total 1 F F-pathway control state Fatty acid oxidation, level 5 607 751 2 N N-pathway control state NADH-linked, level 4 2465 2613 3 S S-pathway control state Succinate-linked, level 3 1678 1786 4 Gp Gp-pathway control state Glycerophosphate-linked, level 3 156 182 5 DQ DQ-pathway control state Duorquinol-linked, level 2 26 31 6 CIV Complex IV single step Ascorbate & TMPD, level 1 700 728 7 NS NS-pathway control state Convergent CI- and CII-linked electron flow to the Q-junction 1572 1628 8 Other combinations Other combinations-pathway control state 131 147 9 ROX Residual oxygen consumption includes non-mitochondrial respiration 1516 1568
MiPMap combinations - examples
- Examples for specific combinations
- O2k-Publications: Human skeletal muscle •• O2k-Publications: Human heart •• O2k-Publications: Skeletal muscle - human vs mouse
- Browse data
